Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06306456
Status:
RECRUITING
Last Update Posted:
2024-07-08
First Post:
2024-02-29
Brief Title:
A Phase IbII Clinical Study of GH21 Capsules Combined With Osimertinib Mesylate Tablets in Patients With NSCLC
Sponsor:
Organization:
Suzhou Genhouse Bio Co Ltd